Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.667,20
0,64%
NASDAQ
18.509,34
0,20%
Bitcoin
64.626,85
-0,35%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Blueprint Medicines Corporation (BPMC) Blueprint Medicines Corporation (BPMC) Notizie

BPMC

Blueprint Medicines (BPMC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC
DataOraFonteTitoloSimboloCompagnia
11/04/202120:00PR Newswire (US)Blueprint Medicines Data Highlight Clinical Leadership in Systemic Mastocytosis at AACR Annual Meeting 2021NASDAQ:BPMCBlueprint Medicines Corporation
10/04/202114:30PR Newswire (US)Blueprint Medicines Presents Preclinical Data Highlighting Broad Precision Therapy Research Pipeline at AACR Annual Meeting 2...NASDAQ:BPMCBlueprint Medicines Corporation
07/04/202122:01PR Newswire (US)Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:BPMCBlueprint Medicines Corporation
05/04/202114:00PR Newswire (US)Blueprint Medicines to Host Virtual Investor Event and Webcast to Review New Data Presented at AACR Annual Meeting on Monday,...NASDAQ:BPMCBlueprint Medicines Corporation
17/03/202122:49Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:BPMCBlueprint Medicines Corporation
17/03/202122:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BPMCBlueprint Medicines Corporation
10/03/202122:30PR Newswire (US)Blueprint Medicines to Showcase Scientific Leadership in Precision Oncology and Hematology at AACR Annual Meeting 2021NASDAQ:BPMCBlueprint Medicines Corporation
03/03/202114:00PR Newswire (US)Blueprint Medicines Announces EMA Validation of Type II Variation Marketing Authorization Application for AYVAKYT® (avapriti...NASDAQ:BPMCBlueprint Medicines Corporation
17/02/202122:52Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BPMCBlueprint Medicines Corporation
17/02/202114:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BPMCBlueprint Medicines Corporation
17/02/202113:00PR Newswire (US)Blueprint Medicines Reports Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
10/02/202116:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BPMCBlueprint Medicines Corporation
10/02/202114:00PR Newswire (US)Blueprint Medicines to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021NASDAQ:BPMCBlueprint Medicines Corporation
03/02/202120:15Edgar (US Regulatory)Schedule 13gNASDAQ:BPMCBlueprint Medicines Corporation
19/01/202122:28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BPMCBlueprint Medicines Corporation
11/01/202114:05PR Newswire (US)Blueprint Medicines Announces R&D Leadership TransitionsNASDAQ:BPMCBlueprint Medicines Corporation
11/01/202114:00PR Newswire (US)Blueprint Medicines Reports Portfolio Milestones and Outlines 2021 Roadmap for Precision Medicine LeadershipNASDAQ:BPMCBlueprint Medicines Corporation
17/12/202014:00PR Newswire (US)Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanc...NASDAQ:BPMCBlueprint Medicines Corporation
07/12/202014:00PR Newswire (US)Blueprint Medicines Data Presented at 62nd ASH Annual Meeting and Exposition Highlight Broad Commitment to Advance Patient Ca...NASDAQ:BPMCBlueprint Medicines Corporation
01/12/202022:12Dow Jones NewsBlueprint Medicines Says FDA Approves Gavreto to Treat Thyroid CancerNASDAQ:BPMCBlueprint Medicines Corporation
01/12/202021:15PR Newswire (US)Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metasta...NASDAQ:BPMCBlueprint Medicines Corporation
23/11/202014:00PR Newswire (US)Blueprint Medicines To Present Broad Range of Data Reinforcing Commitment to Advance Patient Care in Systemic Mastocytosis at...NASDAQ:BPMCBlueprint Medicines Corporation
29/10/202021:20Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BPMCBlueprint Medicines Corporation
29/10/202012:00PR Newswire (US)Blueprint Medicines Reports Third Quarter 2020 Financial ResultsNASDAQ:BPMCBlueprint Medicines Corporation
22/10/202014:00PR Newswire (US)Blueprint Medicines to Report Third Quarter 2020 Financial Results on Thursday, October 29, 2020NASDAQ:BPMCBlueprint Medicines Corporation
25/09/202017:46PR Newswire (US)Blueprint Medicines Announces European Commission Approval of AYVAKYT® (avapritinib) for the Treatment of Adults with Unrese...NASDAQ:BPMCBlueprint Medicines Corporation
22/09/202013:00PR Newswire (US)Blueprint Medicines Announces Positive Top-line Results from EXPLORER and PATHFINDER Trials of AYVAKIT™ (avapritinib) in Pa...NASDAQ:BPMCBlueprint Medicines Corporation
20/09/202014:25PR Newswire (US)Blueprint Medicines Reports ARROW Trial Data at ESMO Virtual Congress 2020 Demonstrating Durable Clinical Benefits of GAVRETO...NASDAQ:BPMCBlueprint Medicines Corporation
17/09/202014:00PR Newswire (US)Blueprint Medicines Presents Foundational Preclinical Data for BLU-945 Showing Robust Anti-Tumor Activity in Treatment-Resist...NASDAQ:BPMCBlueprint Medicines Corporation
09/09/202022:01PR Newswire (US)Blueprint Medicines to Present at 18th Annual Morgan Stanley Global Healthcare ConferenceNASDAQ:BPMCBlueprint Medicines Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPMC

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
FBK
Finecobank
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STMMI
ST Microelectronics
BIT
BC
Brunello Cucinelli
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
TEN
Tenaris
BIT
LDO
Leonardo
BIT
MONC
Moncler
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network